Kenya Medical Research Institute (KEMRI) is poised to obtain a grant of Ksh3 billion aimed at bolstering research capabilities and advancing tropical medicine development. This follows the signing of a Memorandum of Understanding (MoU) by President William Ruto during his trip to Japan.
In a press release issued by the institution, the funding will be allocated towards the establishment of a state-of-the-art training facility for scientists focusing on research and the development of biotechnology products. This initiative aims to bolster readiness in tackling potential biothreats or emerging pandemics.
The research will also focus on the development of cures for HIV/AIDS and other chronic diseases such as cancer.
“KEMRI will receive Ksh3 billion support for more research on the development of tropical medicine to help cure diseases such as cancer and HIV AIDS that will continue to affect many Kenyans at the bottom of the economic pyramid. This is largely through PPs and grants,” Government spokesperson Isaac Mwaura stated.
The center will also house advanced biocontainment laboratories equipped with cutting-edge technology for disease surveillance, pathogen identification, and the design, discovery, and development of drugs, vaccines, and diagnostic kits.
Speaking after the signing of the MoU, KEMRI’s Acting Director General and Chief Executive Officer, Elijah Songok who had accompanied Ruto on the trip lauded the move citing that this investment cemented KEMRI’s forefront position in leading other Kenyan and regional institutions in enhancing research and development for the improved health and wellbeing.
